Chirality underpins all life. Nineteen of the twenty amino
acids contain at least one stereocenter, as do all nucelosides, sugars, and
most metabolites. The very first fragment I ever found was chiral, but that is
not typical, at least judged by those that show up in publications. Only 5 of
the 27 fragment to lead success stories published in 2015 started with a
fragment containing a chiral center. This probably reflects what people choose
to screen and pursue. Chiral centers can lead to challenging chemistry, and
chiral centers also add to molecular complexity.
All of which brings us to the topic of our new poll: do you
include chiral fragments in your primary screening collection? If so, do you
include both enantiomers? Please vote in the poll to the right.
If you do include chiral fragments, do you screen racemic mixtures? Crystallography can sometimes reveal which enantiomer is active if
the quality of the structure is good enough, but woe betide anyone screening
racemic mixtures by ITC! In a new paper in Magn.
Res. Chem., Claudio Dalvit (University of Neuchatel) and Stefan Knapp (Goethe
University Frankfurt) show that fluorine NMR can also be used to screen racemic
mixtures.
As Teddy wrote more than five years ago, 19F NMR
is “just like 1H NMR”. Most applications of 19F rely on
detecting the line broadening that occurs when a fluorine-containing fragment
binds to a protein. However, the chemical shift of the fluorine atom(s) can
also change, particularly if the ligand forms hydrogen bonds to the protein. This
“chemical shift perturbation” can be large enough to be detectable.
In the absence of protein, 19F NMR shows the same
signal for different enantiomers, so a racemic ligand containing a single trifluoromethyl
group gives a single sharp peak. However, upon addition of a protein that binds
one enantiomer, the signal splits into two; one remains sharp and retains essentially
the same chemical shift, while the other becomes broader and moves. The researchers
show this both theoretically and experimentally with a racemic fragment that
binds to the bromodomain BRD4. Adding a high-affinity ligand that binds to the
same site displaces the fragment, causing the two signals to again converge.
Unfortunately there is no X-ray structure of the ligand bound
to the protein, and the two pure enantiomers were not tested individually. And
of course, unlike crystallography, 19F NMR does not reveal which enantiomer in a racemic mixture
binds. Still, enantioselective binding can itself be indicative of specific
binding, as opposed to various artifacts, and the researchers recommend that “racemates
should always be included in the generation of the fluorinated fragment
libraries.” What do you think?
No comments:
Post a Comment